The management of thalassemia major.
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D002614:Chelating Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000627:therapeutic use; D004035:Diet Therapy; D004700:Endocrine System Diseases / Q000209:etiology; D004912:Erythrocytes; D005705:Gallbladder Diseases / Q000209:etiology; D006130:Growth Disorders / Q000209:etiology; D006192:Haemophilus Infections / Q000209:etiology; D006193:Haemophilus influenzae; D006331:Heart Diseases / Q000209:etiology; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000652:urine; D008107:Liver Diseases / Q000209:etiology; D009929:Organ Size; D011008:Pneumococcal Infections / Q000209:etiology; D011183:Postoperative Complications; D013117:Spinal Cord Compression / Q000209:etiology; D013156:Splenectomy; D013789:Thalassemia / Q000235:genetics / Q000628:therapy*; D014815:Vitamins / Q000627:therapeutic use
D002614:Chelating Agents; D014815:Vitamins; D007501:Iron; D003676:Deferoxamine